Therapies Using Zanolimumab To Enhance The Immune Response
Technology
E-200-2010
Patent ID
E-200-2010-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
61/328,896
IC
NCI
Date Filed
Date Issued
Patent PDF